featured
Impact of TP53 on Outcomes of Patients With Myelofibrosis Undergoing HSCT
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation
Blood 2023 Mar 20;[EPub Ahead of Print], N Gagelmann, A Badbaran, RB Salit, T Schroeder, C Gurnari, S Pagliuca, V Panagiota, C Rautenberg, B Cassinat, FR Thol, C Wolschke, M Robin, M Heuser, MT Rubio, JP Maciejewski, HC Reinhardt, BL Scott, N KrögerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.